asthma
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: (1) Details of drug therapy are not restricted. (2) One or more specific IgE antibodies must be positive.
Exclusion criteria
Exclusion criteria: (1) Patients cannot install air purifier at home because of this large size or other reasons. (2) Patients with cognitive impairment. (3) Patients with chronic pneumothorax. (4) Patients with unstable conditions due to a new pneumothorax occurring within the past 4 weeks. (5) Patients with unstable conditions due to asthma exacerbation or airway infection within the past 4 weeks. (6) Patients with pre-existing plans to be away from home for 7 days or more during the observation and intervention periods.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Difference in change in FEV1 between patients using air purifiers with HEPA filters and those using air purifiers without HEPA filters | — |
Secondary
| Measure | Time frame |
|---|---|
| (1) Difference in FVC change between patients using air purifiers with HEPA filters and those using air purifiers without HEPA filters. (2) Difference in ACT between patients using air purifiers with HEPA filters and those using air purifiers without HEPA filters. (3) Difference in CAAT between patients using air purifiers with HEPA filters and those using air purifiers without HEPA filters. (4) Difference in FeNO between patients using air purifiers with HEPA filters and those using air purifiers without HEPA filters. (5) Difference in change in allergens obtained from petri dishes placed in bedroom between patients using air purifiers with HEPA filters and those using air purifiers without HEPA filters. (6) Difference in change in allergens obtained from air purifier filters between patients using air purifiers with HEPA filters and those using air purifiers without HEPA filters. (7) Difference in microbial changes obtained from air purifier filters between patients using air purifiers with HEPA filters and those using air purifiers without HEPA filters. (8) Difference in microbial changes obtained from skin swabs between patients using air purifiers with HEPA filters and those using air purifiers without HEPA filters. (9) Differences in changes in air quality sensor data between patients using air purifiers with HEPA filters and those using air purifiers without HEPA filters. (10) Differences in changes in Th2-related inflammatory markers in blood tests between patients using air purifiers with HEPA filters and those using air purifiers without HEPA filters. (11) Differences in changes in air quality sensor data between patients using air purifiers with HEPA filters and those using air purifiers without HEPA filters due to differences in outdoor environmental data. | — |
Countries
Japan
Contacts
Graduate School of Medicine, Kyoto University Department of Advanced Medicine for Respiratory Failure